• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epigenetic Changes Mediated by miR29 Activate Cyclooxygenase-2 and Interferon-λ1 Production during Viral Infection

tetano

Editor, Senior Moderator
J Virol. 2011 Nov 9. [Epub ahead of print]
Epigenetic Changes Mediated by miR29 Activate Cyclooxygenase-2 and Interferon-λ1 Production during Viral Infection.
Fang J, Hao Q, Liu L, Li Y, Wu J, Huo X, Zhu Y.
Source

The State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China.
Abstract

Interferon (IFN)-λ1 and cyclooxygenase (COX)-2 were reported to play an important role in host antiviral defense. However, the mechanism by which IFN-λ1 and COX2 is activated and modulated during viral infection remains unclear. In this study, we found that expression of both circulating IFN-λ1 and COX2-derived PGE2 was coordinately elevated in a cohort of influenza patients compared to healthy individuals. Expression of IFN-λ1 was blocked by a selective COX2 inhibitor during influenza A virus infection in A549 human lung epithelial cells, but enhanced by overexpression of COX2, indicating that production of IFN-λ1 is COX2 dependent. COX2 was able to increase IFN-λ1 expression by promoting NF-κB binding to the enhancer in IFN-λ1 promoter. We found that Epigenetic changes activate COX2 expression and PGE2 accumulation during viral infection. The expression of DNA methyltransferase (DNMT) 3a and DNMT3b, but not DNMT1, was down-regulated following influenza A virus infection both in A549 cells and peripheral blood mononuclear cells (PBMCs). We showed that microRNA(miR)29 suppresses DNMT activity and thus induces expression of COX2 and PGE2. Furthermore, miR29 expression was elevated 50-fold in virally-infected A549 cells and 10-fold in PBMCs from influenza patients, compared to expression after mock infection of A549 cells or in healthy individuals, respectively. Activation of the protein kinase A signaling pathway and phosphorylation of CREB1 also contributed to COX2 expression. Collectively, our work defines a novel proinflammatory cascade in the control of influenza A virus infection.

PMID:
22072783
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22072783
 
Back
Top Bottom